Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2011 2
2012 8
2013 9
2014 2
2015 5
2016 3
2017 5
2018 3
2019 1
2020 8
2021 9
2022 9
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
Evidence-based medicine in urology.
Dahm P, Kunath F. Dahm P, et al. Among authors: kunath f. World J Urol. 2020 Mar;38(3):515-516. doi: 10.1007/s00345-020-03139-6. World J Urol. 2020. PMID: 32112241 No abstract available.
[Screening for urological tumors].
Kunath F. Kunath F. MMW Fortschr Med. 2023 Sep;165(15):50-56. doi: 10.1007/s15006-023-2833-z. MMW Fortschr Med. 2023. PMID: 37653320 German. No abstract available.
Degarelix for treating advanced hormone-sensitive prostate cancer.
Zengerling F, Jakob JJ, Schmidt S, Meerpohl JJ, Blümle A, Schmucker C, Mayer B, Kunath F. Zengerling F, et al. Among authors: kunath f. Cochrane Database Syst Rev. 2021 Aug 5;8(8):CD012548. doi: 10.1002/14651858.CD012548.pub2. Cochrane Database Syst Rev. 2021. PMID: 34350976 Free PMC article. Review.
Immunotherapy for advanced or metastatic urothelial carcinoma.
Maisch P, Hwang EC, Kim K, Narayan VM, Bakker C, Kunath F, Dahm P. Maisch P, et al. Among authors: kunath f. Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD013774. doi: 10.1002/14651858.CD013774.pub2. Cochrane Database Syst Rev. 2023. PMID: 37811690 Review.
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review.
Schmidt S, Kunath F, Coles B, Draeger DL, Krabbe LM, Dersch R, Kilian S, Jensen K, Dahm P, Meerpohl JJ. Schmidt S, et al. Among authors: kunath f. Investig Clin Urol. 2020 Jul;61(4):349-354. doi: 10.4111/icu.2020.61.4.349. Epub 2020 Jun 29. Investig Clin Urol. 2020. PMID: 32665991 Free PMC article. Review. No abstract available.
61 results